Stage IIIC Cutaneous Melanoma AJCC v7 Suspended Phase 2 Trials for Nelfinavir (DB00220)

IndicationStatusPhase
DBCOND0091049 (Stage IIIC Cutaneous Melanoma AJCC v7)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03050060Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney CancerTreatment